An Exposure-Response Threshold for Lung Diseases and Lung Cancer Caused by Crystalline Silica

• Published in: Risk analysis 2011-10, Vol.31 (10), p.1543-1560
• Main Author: Cox, Jr, Louis Anthony (Tony)
• Format: Article
• Language: English
• Subjects: Analysis; Cancer; Crystalline silica; Crystallization; Diseases; dose-response model; Dose-Response Relationship, Drug; Epidemiology; exposure-response; Hazardous products; Human exposure; Humans; Lung - metabolism; Lung cancer; lung cancer risk; Lung diseases; Lung Diseases - chemically induced; Lung Diseases - metabolism; mathematical model; Neutrophils; Occupational Exposure; Reactive Nitrogen Species - metabolism; Reactive Oxygen Species; Risk; Risk management; Silicon Dioxide - chemistry; Silicon Dioxide - toxicity; Silicosis; Studies; Toxicity; Tumor Necrosis Factor-alpha - metabolism
• ISSN: 0272-4332; 1539-6924
• DOI: 10.1111/j.1539-6924.2011.01610.x

Whether crystalline silica (CS) exposure increases risk of lung cancer in humans without silicosis, and, if so, whether the exposure‐response relation has a threshold, have been much debated. Epidemiological evidence is ambiguous and conflicting. Experimental data show that high levels of CS cause lung cancer in rats, although not in other species, including mice, guinea pigs, or hamsters; but the relevance of such animal data to humans has been uncertain. This article applies recent insights into the toxicology of lung diseases caused by poorly soluble particles (PSPs), and by CS in particular, to model the exposure‐response relation between CS and risk of lung pathologies such as chronic inflammation, silicosis, fibrosis, and lung cancer. An inflammatory mode of action is described, having substantial empirical support, in which exposure increases alveolar macrophages and neutrophils in the alveolar epithelium, leading to increased reactive oxygen species (ROS) and nitrogen species (RNS), pro‐inflammatory mediators such as TNF‐alpha, and eventual damage to lung tissue and epithelial hyperplasia, resulting in fibrosis and increased lung cancer risk among silicotics. This mode of action involves several positive feedback loops. Exposures that increase the gain factors around such loops can create a disease state with elevated levels of ROS, TNF‐alpha, TGF‐beta, alveolar macrophages, and neutrophils. This mechanism implies a “tipping point” threshold for the exposure‐response relation. Applying this new model to epidemiological data, we conclude that current permissible exposure levels, on the order of 0.1 mg/m3, are probably below the threshold for triggering lung diseases in humans.